Dietary α-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells

Journal of Lipid Research

Volumn 45, Issue 2, 2004, Pages 308-316

  Vecchini, A ^a   Ceccarelli, V ^a   Susta, F ^a   Caligiana, P ^a   Orvietani, P ^a   Binaglia, L ^a   Nocentini, G ^a   Riccardi, C ^a   Calviello, G ^b   Palozza, P ^b   Maggiano, N ^b   Di Nardo, P ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Cyclooxygenase 2; Polyunsaturated fatty acids; Sterol regulatory element binding protein 1

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A OXIDASE; CARNITINE PALMITOYLTRANSFERASE; CCAAT ENHANCER BINDING PROTEIN; CYCLOOXYGENASE 2; FATTY ACID SYNTHASE; LINOLENIC ACID; MALONYL COENZYME A; MESSENGER RNA; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID ANALYSIS; FOOD INTAKE; HEPATOMA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ACETYL-COA CARBOXYLASE; ALPHA-LINOLENIC ACID; ANIMALS; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEINS; CYCLOOXYGENASE 2; DIET; DIETARY FATS, UNSATURATED; DOWN-REGULATION; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION, NEOPLASTIC; ISOENZYMES; LIVER NEOPLASMS, EXPERIMENTAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS;

EID: 10744224371     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300396-JLR200     Document Type: Article

References (64)

1. Alo, P. L., P. Visca, A. Marci, A. Mangoni, C. Botti, and U. Di Tondo. 1996. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 77: 474-482.
2. Visca, P., V. Sebastiani, E. S. Pizer, C. Botti, P. De Carli, S. Filippi, S. Monaco, and P. L. Alo. 2003. Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma. Anticancer Res. 23: 335-339.
3. Pizer, E., S. Lax, F. Kuhajda, G. Pasternack, and R. Kurman. 1998. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer. 83: 528-537.
4. Rashid, A., E. S. Pizer, M. Moga, L. Z. Milgraum, M. Zahurak, G. R. Pasternack, F. P. Kuhajda, and S. R. Hamilton. 1997. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am. J. Pathol. 150: 201-208.
5. Swinnen, J. V., T. Roskams, S. Joniau, H. Van Poppel, R. Oyen, L. Baert, W. Heyns, and G. Verhoeven. 2002. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int. J. Cancer. 98: 19-22.
6. Yang, Y-A., W. F. Han, P. J. Morin, F. J. Chrest, and E. S. Pizer. 2002. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp. Cell Res. 279: 80-90.
7. Yang, Y-A., P. J. Morin, W. F. Han, T. Chen, D. M. Bornman, E. W. Gabrielson, and E. S. Pizer. 2003. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp. Cell Res. 282: 132-137.
8. Swinnen, J. V., H. Heemers, L. Deboel, F. Foufelle, W. Heyns, and G. Verhoeven. 2000. Stimulation of tumour-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene. 19: 5173-5181.
9. Heemers, H., B. Maes, F. Foufelle, W. Heyns, G. Verhoeven, and J. V. Swinnen. 2001. Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein. Mol. Endocrinol. 15: 1817-1828.
10. Li, J. N., M. A. Mahmoud, W. F. Han, M. Ripple, and E. S. Pizer. 2000. Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp. Cell Res. 261: 159-165.
11. Nohturfft, A., R. A. DeBose-Boyd, S. Scheek, J. L. Goldstein, and M. S. Brown. 1999. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc. Natl. Acad. Sci. USA. 96: 11235-11240.
12. Worgall, T. S., S. L. Sturley, T. Seo, T. F. Osborne, and R. J. Deckelbaum. 1998. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem. 273: 25537-25540.
13. Moon, Y. S., M-J. Latasa, M. J. Griffin, and H. S. Sul. 2002. Suppression of fatty acid synthase promoter by polyunsaturated fatty acids. J. Lipid Res. 43: 691-698.
14. Pizer, E. S., C. Jackisch, F. D. Wood, G. R. Pasternack, N. E. Davidson, and F. P. Kuhajda. 1996. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res. 56: 2745-2747.
15. Kuhajda, F. P., E. S. Pizer, J. N. Li, N. S. Mani, G. L. Frehywot, and C. A. Townsend. 2000. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl. Acad. Sci. USA. 97: 3450-3454.
16. Li, J. N., M. Gorospe, F. J. Chrest, T. S. Kumaravel, M. K. Evans, W. F. Han, and E. S. Pizer. 2001. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res. 61: 1493-1499.
17. Pizer, E. S., F. J. Chrest, J. A. DiGiuseppe, and W. F. Han. 1998. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res. 58: 4611-4615.
18. Calviello, G., P. Palozza, E. Piccioni, N. Maggiano, A. Frattucci, P. Franceschelli, and G. M. Bartoli. 1998. Dietary supplementation with elcosapentaenoic and docosahexaenoic acid inhibit growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int. J. Cancer. 75: 699-705.
19. Diggle, C. P. 2002. In vitro studies on the relationship between polyunsaturated fatty acids and cancer: tumour or tissue specific effects? Prog. Lipids Res. 41: 240-253.
20. Hirose, M., A. Masuda, N. Ito, K. Kamano, and H. Okuyama. 1990. Effects of dietary perilla oil, soybean oil and safflower oil on 7,12-dimethylbenz[a]anthracene (DMBA) and 1,2-dimethyl-hydrazine (DMH)-induced mammary gland and colon carcinogenesis in female SD rats. Carcinogenesis. 11: 731-735.
21. Reddy, B. S., C. Burill, and J. Rigotty. 1991. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res. 51: 487-491.
22. Karmali, R. A., J. Marsh, and C. Fuchs. 1984. Effect of omega-3 fatty acids on growth of a rat mammary tumor. J. Natl. Cancer Inst. 73: 457-461.
23. Hudson, E. A., S. A. Beck, and M. J. Tisdale. 1993. Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid. Biochem. Pharmacol. 45: 2189-2194.
24. 3H-thymidine incorporation in hepatoma 7288CTC perfused in situ. Br. J. Cancer. 66: 297-303.
25. Horrobin, D. F. 1990. Essential fatty acids, lipid peroxidation, and cancer. In ω-6 Essential Fatty Acids. D. F. Horrobin, editor. Wiley-Liss, New York. 351-378.
26. Pizer, E. S., J. Thupari, W. F. Han, M. L. Pinn, F. J. Chrest, G. L. Frehywot, C. A. Townsend, and F. P. Kuhajda. 2000. Malonyl-coenzyme A is a potent mediator of cytotoxicity induced by fatty acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 60: 213-218.
27. Bagga, D., L. Wang, R. Farias-Eisner, J. A. Glaspy, and S. T. Reddy. 2003. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA. 100: 1751-1756.
28. Gavriely, Y., Y. Sherman, and S. A. Sasson. 1992. Identification of programmed cells death in situ via specific labelling DNA fragmentation. J. Cell Biol. 119: 493-501.
29. Folch, J., M. Lees, and G. M. Sloane-Stanley. 1957. A simplified method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
30. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonudease. Biochemistry. 18: 5294-5299.
31. Kim, J., P. Tontoz, and B. Spiegelman. 1993. Add1: a novel helix-loop-helix protein associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13: 4753-4759.
32. Inoue, J., and R. Sato. 1999. A novel splicing isoform of mouse sterol regulatory element-binding protein-1 (SREBP-1). Biosci. Biotechnol. Biochem. 63: 243-245.
33. Amy, C. M., A. Witkowski, J. Naggert, B. Williams, Z. Randhawa, and S. Smith. 1989. Molecular cloning and sequencing of cDNAs encoding the entire rat fatty acid synthase. Proc. Natl. Acad. Sci. USA. 86: 3114-3118.
34. Lopez-Casillas, F., D. H. Bai, X. N. Luo, I. S. Kong, M. A. Hermodson, and K. H. Kim. 1988. Structure of the coding sequence and primary amino acid sequence of acetyl-coenzyme A carboxylase. Proc. Natl. Acad. Sci. USA. 85: 5784-5788.
35. Elshourbagy, N. A., J. C. Near, P.J. Kmetz, G. M. Sathe, C. Southan, J. E. Strickler, M. Gross, J. F. Young, T. N. Wells, and P. H. Groot. 1990. Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ and age. J. Biol. Chem. 265: 1430-1435.
36. Goettlicher, M., E. Widmark, Q. Li, and J. A. Gustafsson. 1992. Fatty acid activate a chimera of the clofibric acid-activated receptor and glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 89: 4653-4657.
37. Esser, V., C. H. Britton, B. C. Weis, D. W. Foster, and J. D. McGarry. 1993. Cloning, sequencing and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. J. Biol. Chem. 268: 5817-5822.
38. Miyazawa, S., H. Hayashi, M. Hijikata, N. Ishii, H. Kagamiyama, T. Osumi, and T. Hashimoto. 1987. Complete nucleotide sequence of cDNA and predicted sequence of rat acyl-CoA oxidase. J. Biol. Chem. 262: 8131-8137.
39. Hua, X., A. Nohturfft, J. L. Goldstein, and M. S. Brown. 1996. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell. 87: 415-426.
40. Seidah, N. G., S. J. Mowla, J. Hamelin, A. M. Mamarbachi, S. Benjannet, B. B. Toure, A. Basak, J. S. Munzer, J. Marcinkiewicz, M. Zhong, J. C. Barale, C. Lazure, R. A. Murphy, M. Chretien, and M. Marcinkiewicz. 1999. Mammalian subtilisin/kexin isozyme SKI-1. A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. Proc. Natl. Acad. Sci. USA. 96: 1321-1326.
41. Rawson, R. B., N. G. Zelenski, D. Nijhawan, J. Ye, J. Sakai, M. T. Hasan, T. Y. Chang, M. S. Brown, and J. L. Goldstein. 1997. Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell. 1: 47-57.
42. Lincoln, A.J., S. C. Williams, and P. F. Johnson. 1994. A revised sequence of the rat C/EBP gene. Genes Dev. 8: 1131-1132.
43. Descombes, P., M. Chojkier, S. Lichtsteiner, E. Falvey, and U. Schibler. 1990. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev. 4: 1541-1551.
44. Kageyama, R., Y. Sasai, and S. Nakanishi. 1991. Molecular characterization of transcription factors that bind to the cAMP responsive region of the substance P precursor gene. cDNA cloning of a novel C/EBP-related factor. J. Biol. Chem. 266: 15525-15531.
45. Feng, L., W. Sun, Y. Xia, W. W. Tang, P. Chanmugam, E. Soyoola, C. B. Wilson, and D. Hwang. 1993. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys. 307: 361-368.
46. Blanquicett, C., M. R. Johnson, M. Heslin, and R. B. Diasio. 2002. Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies. Anal. Biochem. 303: 209-214.
47. Xu, J., T. Nakamura, H. P. Cho, and S. D. Clarke. 1999. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. J. Biol. Chem. 274: 23577-23583.
48. Demoz, A., A. Garras, D. K. Asiedu, B. Netteland, and R. K. Berge. 1995. Rapid method for the separation and detection of tissue short-chain coenzyme A esters by reversed-phase high-performance liquid chromatography. J. Chromatogr. 667: 148-152.
49. Caivano, M., B. Gorgoni, P. Cohen, and V. Poli. 2001. The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding proteinβ (C/EBPβ) and C/EBPδ transcription factors. J. Biol. Chem. 276: 48693-48701.
50. Casado, M., N. A. Callejas, J. Rodrigo, X. Zhao, S. K. Dey, L. Bosca, and P. Martin-Sanz. 2001. Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy. FASEB J. 15: 2016-2018.
51. Cao, Y., and S. M. Prescott. 2002. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J. Cell. Physiol. 190: 279-286.
52. Stephen, M., F. A. Perscott, and F. A. Fritzpatrick. 2000. Cydooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta. 1470: M69-M78.
53. Woutersen, R. A., M.J. Appel, A. van Garderen-Hoetmer, and V. W. Wijnands. 1999. Dietary fat and carcinogenesis. Mutat. Res. 443: 111-127.
54. Marnett, L. J. 1994. Generation of mutagens during arachidonic acid metabolism. Cancer Metastasis Rev. 13: 303-308.
55. Hu, K. Q., C. H. Yu, Y. Mineyama, J. D. McCracken, D. J. Hillebrand, and M. Hasan. 2003. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Int. J. Oncol. 22: 757-763.
56. Shiota, G., M. Okubo, T. Noumi, N. Noguchi, K. Oyama, Y. Takano, K. Yashima, Y. Kishimoto, and H. Kawasaki. 1999. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology. 46: 407-412.
57. Qiu, D. K., X. Ma, Y. S. Peng, and X. Y. Chen. 2002. Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma. World J. Gastroenterol. 8: 815-817.
58. Koga, H., S. Sakisaka, M. Ohishi, T. Kawaguchi, E. Taniguchi, K. Sasatomi, M. Harada, T. Kusaba, M. Tanaka, R. Kimura, Y. Nakashima, O. Nakashima, M. Kojiro, T. Kurohiji, and M. Sata. 1999. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology. 29: 688-696.
59. Bae, S. H., E. S. Jung, Y. M. Park, B. S. Kim, B. K. Kim, D. G. Kim, and W. S. Tyu. 2001. Expression of cydooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin. Cancer Res. 7: 1410-1418.
60. Tian, G., J. P. Yu, H. S. Luo, B. P. Yu, H. Yue, J. Y. Li, and Q. Mei. 2002. Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells. World J. Gastroenterol. 8: 483-487.
61. Kern, M. A., D. Schubert, D. Sahi, M. M. Schoneweiss, I. Moll, A. M. Haugg, H. P. Dienes, K. Breuhahn, and P. Schirmacher. 2002. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology. 36: 885-894.
62. Gorgoni, B., M. Caivano, C. Arizmendi, and V. Poli. 2001. The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J. Biol. Chem. 276: 40769-40777.
63. Ramji, D. P., and P. Foka. 2002. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365: 561-575.
64. Jelinska, M., A. Tokarz, R. Oledzka, and A. Czorniuk-Sliwa. 2003. Effects of dietary linseed, evening primrose or fish oils on fatty acid and prostaglandin E2 contents in the rat livers and 7,12-dimethylbenz[a]anthracene-induced tumours. Biochim. Biophys. Acta. 1637: 193-199.